Beth Wilmot Selected Research

Beth Wilmot Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 10/2011
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 06/2015
5	Leukemia 01/2020 - 05/2013
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020 - 01/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 06/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 10/2011
1	Vascular Diseases (Vascular Disease) 01/2021
1	Genetic Risk Score 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 12/2019
1	Ocular Toxoplasmosis 01/2019
1	Infections 01/2019
1	Juvenile Myelomonocytic Leukemia 01/2018
1	Hypernatremia 08/2017
1	Chronic Neutrophilic Leukemia 01/2017
1	Neutropenia 01/2017
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2015
1	Otitis Media 01/2015
1	Otitis Media with Effusion 05/2014
1	Type V Osteogenesis Imperfecta 12/2013
1	Kidney Diseases (Kidney Disease) 02/2012
1	Dental Caries (Decay, Dental) 01/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2010
1	Hyponatremia 08/2009
1	Cognitive Dysfunction 04/2008
1	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 07/2006
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2006
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2006
1	Parkinson Disease (Parkinson's Disease) 07/2006
1	Karak Syndrome 07/2006
1	Neurodegeneration with brain iron accumulation (NBIA) 07/2006
1	Alzheimer Disease (Alzheimer's Disease) 07/2006

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 01/2022 - 05/2013
4	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 02/2016 - 05/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016 - 05/2013
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 10/2011
2	SodiumIBA 02/2012 - 08/2009
1	Aurora Kinase AIBA 11/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Unithiol (DMPS)IBA 01/2020
1	venetoclaxIBA 01/2020
1	crenolanibIBA 01/2019
1	Retinal Pigments (Pigments, Visual)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Protein Tyrosine PhosphatasesIBA 01/2018
1	ElectrolytesIBA 08/2017
1	Cysteine (L-Cysteine)FDA Link 01/2017
1	Fibronectins (Fibronectin)IBA 01/2017
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 01/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 12/2015
1	src-Family KinasesIBA 12/2015
1	Dasatinib (BMS 354825)FDA Link 12/2015
1	Anaplastic Lymphoma KinaseIBA 06/2015
1	Toll-Like Receptor 4IBA 01/2015
1	Methionine (L-Methionine)FDA Link 12/2013
1	Initiator Codon (Start Codon)IBA 12/2013
1	NucleotidesIBA 12/2013
1	LigandsIBA 01/2013
1	Androgen Receptors (Androgen Receptor)IBA 01/2013
1	FluoridesIBA 01/2012
1	ParaffinIBA 10/2011
1	ChromatinIBA 10/2011
1	A-Form DNA (A-DNA)IBA 10/2011
1	Imatinib Mesylate (Gleevec)FDA Link 01/2010
1	CalciumIBA 07/2006
1	IronIBA 07/2006
1	Phospholipases A2 (Phospholipase A2)IBA 07/2006
1	Group VI Phospholipases A2IBA 07/2006
1	Phospholipases (Phospholipase)IBA 07/2006

Therapy/Procedure

5	Therapeutics 11/2021 - 01/2010
1	Precision Medicine 01/2016
1	Castration 01/2013